Citation Impact
Citing Papers
Origins and evolution of the Western diet: health implications for the 21st century1,2
2005 Standout
MiRP1 Forms IKr Potassium Channels with HERG and Is Associated with Cardiac Arrhythmia
1999 Standout
Reproducibility of quantitative (R)-[11C]verapamil studies
2012
Multidrug resistance in cancer: role of ATP–dependent transporters
2002 Standout
Pulmonary thromboembolism in Asians/Pacific Islanders in the United States: analysis of data from the National Hospital Discharge Survey and the United States Bureau of the Census
2004
CYP1A2 and CYP2D6 4-Hydroxylate Propranolol and Both Reactions Exhibit Racial Differences
2000
A diverse family of thermostable cytochrome P450s created by recombination of stabilizing fragments
2007 StandoutNobel
Cytochrome P450 2C9 (CYP2C9) and vitamin K epoxide reductase (VKORC1) genotypes as determinants of acenocoumarol sensitivity
2005
Pharmacology and Management of the Vitamin K Antagonists
2008 Standout
Therapeutic potential of resveratrol: the in vivo evidence
2006 Standout
Cytochrome P450 3A5 Genotype is Associated with Verapamil Response in Healthy Subjects
2007
Verapamil
1989
Effects of the Antifungal Agents on Oxidative Drug Metabolism
2000
Interactions Between Antiretroviral Drugs and Drugs Used for the Therapy of the Metabolic Complications Encountered During HIV Infection
2002
Phase I crossover study of paclitaxel with r-verapamil in patients with metastatic breast cancer.
1996
Ginseng pharmacology
1999 Standout
Plasma S/R ratio of warfarin co-varies with VKORC1 haplotype
2007 StandoutNobel
Vascularized and functional human liver from an iPSC-derived organ bud transplant
2013 StandoutNature
Preparation of human metabolites of propranolol using laboratory‐evolved bacterial cytochromes P450
2005 StandoutNobel
Quantitative analysis of complex protein mixtures using isotope-coded affinity tags
1999 Standout
Cytochrome P-450 Polymorphisms and Response to Clopidogrel
2008 Standout
Oral Anticoagulant Therapy
2012 Standout
Charitable State-Controlled Foundation Human Tissue and Cell Research: Ethic and Legal Aspects in the Supply of Surgically Removed Human Tissue For Research in the Academic and Commercial Sector in Germany
2003 Standout
Clinical Significance of the Cytochrome P450 2C19 Genetic Polymorphism
2002
Metabolic Activity and mRNA Levels of Human Cardiac CYP450s Involved in Drug Metabolism
2010
A molecular basis for cardiac arrhythmia: HERG mutations cause long QT syndrome
1995 Standout
In Vitro Approaches to Predicting Drug Interactions In Vivo
1998
Prediction of Drug Clearance in Children: Impact of Allometric Exponents, Body Weight, and Age
2007
A Panel of Cytochrome P450 BM3 Variants to Produce Drug Metabolites and Diversify Lead Compounds
2009 StandoutNobel
Bioavailability enhancers of herbal origin: An overview
2013 Standout
Mechanism-Based Inhibition of Cytochrome P450 3A4 by Therapeutic Drugs
2005
Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy
2020 Standout
Targeting multidrug resistance in cancer
2006 Standout
CYP2C9 Genotype-guided Warfarin Prescribing Enhances the Efficacy and Safety of Anticoagulation: A Prospective Randomized Controlled Study
2007
Genetic and clinical factors relating to warfarin dosing
2009
Clinically Significant Pharmacokinetic Interactions Between Dietary Caffeine and Medications
2000
Prediction of binding modes for ligands in the cytochromes P450 and other heme‐containing proteins
2005
Common VKORC1 and GGCX polymorphisms associated with warfarin dose
2005
Effect of St John's wort on imatinib mesylate pharmacokinetics
2004
Pharmacological Importance of Stereochemical Resolution of Enantiomeric Drugs
1997
Dietary Salt, Urinary Calcium, and Kidney Stone Risk
2009
A genotyping method for VKORC1 1173C>T by Pyrosequencing®technology
2008 StandoutNobel
Treatment of cardiac arrhythmias during pregnancy
1993
Pharmacokinetics in the newborn
2003
Matching chelators to radiometals for radiopharmaceuticals
2013 Standout
Differential Induction of Prehepatic and Hepatic Metabolism of Verapamil by Rifampin
1996
A review on emerging contaminants in wastewaters and the environment: Current knowledge, understudied areas and recommendations for future monitoring
2014 Standout
Clinical relevance of cardiac arrhythmias generated by afterdepolarizations
1994
Polymorphic Cytochrome P450 2D6: Humanized Mouse Model and Endogenous Substrates
2004
Enantioselective Aspects of Drug Action and Disposition: Therapeutic Pitfalls
1989
Coffee and Health: A Review of Recent Human Research
2006 Standout
Verapamil increases the survival of patients with anthracycline-resistant metastatic breast carcinoma
2000
Herb-Drug Interactions
2005 Standout
Piperine, a Major Constituent of Black Pepper, Inhibits Human P-glycoprotein and CYP3A4
2002
Pharmacokinetic Drug Interactions of New Antidepressants: A Review of the Effects on the Metabolism of Other Drugs
1997
Grapefruit juice–drug interactions
1998
Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation
2013 Standout
Cytochromes of the P450 2C subfamily are the major enzymes involved in the O-demethylation of verapamil in humans
1995
Bioluminescent sensor proteins for point-of-care therapeutic drug monitoring
2014 StandoutNobel
Cellular and Ionic Mechanisms Underlying Erythromycin-Induced Long QT Intervals and Torsade de Pointes
1996
Main haplotypes and mutational analysis of vitamin K epoxide reductase (VKORC1) in a Swedish population: a retrospective analysis of case records
2006 StandoutNobel
SCN5A mutations associated with an inherited cardiac arrhythmia, long QT syndrome
1995 Standout
Molecular Docking: A Powerful Approach for Structure-Based Drug Discovery
2011 Standout
Determination of the R,R- and S,S-enantiomers of vamicamide in human serum and urine by high-performance liquid chromatography on a Chiral-AGP column
1993 StandoutNobel
Updated U.S. Public Health Service Guidelines for the Management of Occupational Exposures to HIV and Recommendations for Postexposure Prophylaxis
2005 Standout
Tumour stem cells and drug resistance
2005 Standout
Standards of laboratory practice: cardiac drug monitoring
1998
Cytochrome P450 2C8 Pharmacogenetics: A Review of Clinical Studies
2009
Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cells
1991 Standout
Cardiovascular effects of Danshen
2007 Standout
Pharmacokinetic evaluation in man of terbutaline given as separate enantiomers and as the racemate.
1989
2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death
2015 Standout
Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America
2016 Standout
Dynamic Inversion of Stereoselective Phosphate Binding to a Bisurea Receptor Controlled by Light and Heat
2015 StandoutNobel
Exosomes with Immune Modulatory Features Are Present in Human Breast Milk
2007 Standout
A systematic review of atypical antipsychotic drugs in schizophrenia
2003
Pharmaceuticals of Emerging Concern in Aquatic Systems: Chemistry, Occurrence, Effects, and Removal Methods
2019 Standout
COVID-19 and its implications for thrombosis and anticoagulation
2020 Standout
Citrus flavonoids: Molecular structure, biological activity and nutritional properties: A review
2007 Standout
Practice Guideline for the Treatment of Patients With Obsessive-Compulsive Disorder
2008 Standout
Applications of isotope dilution‐mass spectrometry in clinical chemistry, pharmacokinetics, and toxicology
1992
Dynamic Inversion of Stereoselective Phosphate Binding to a Bisurea Receptor Controlled by Light and Heat
2015 StandoutNobel
Chiral drugs: an overview.
2006
Importance of amine pKa and distribution coefficient in the metabolism of fluorinated propranolol derivatives. Preparation, identification of metabolite regioisomers, and metabolism by CYP2D6.
2001
Part 14: Pediatric Advanced Life Support
2010 Standout
Stereospecific pharmacokinetics and pharmacodynamics of beta-adrenergic blockers in humans.
2001
Systematic reviews: CRD's guidance for undertaking reviews in health care
2010 Standout
A novel sequence variant in exon 7 of CYP2C9 gene (CYP2C9*24) ina patient on warfarin therapy
2006
Works of H Echizen being referenced
Metabolism of warfarin enantiomers in Japanese patients with different CYP2C9/2C19 genotypes.
1998
A potent inhibitory effect of erythromycin and other macrolide antibiotics on the mono-N-dealkylation metabolism of disopyramide with human liver microsomes.
1993
Stereoselective disposition and metabolism of disopyramide in pediatric patients.
1991
Metabolic disposition of imipramine in oriental subjects: relation to metoprolol alpha-hydroxylation and S-mephenytoin 4'-hydroxylation phenotypes.
1994
Pharmacogenetics of CYP2C9 and interindividual variability in anticoagulant response to warfarin
2003
Correlations between in vitro affinity of antipsychotics to various central neurotransmitter receptors and clinical incidence of their adverse drug reactions
1999
The effects of rifampicin on the pharmacokinetics and pharmacodynamics of orally administered nilvadipine to healthy subjects
2002
Developmental changes in the liver weight- and body weight-normalized clearance of theophylline, phenytoin and cyclosporine in children
2002
Electrophysiologic Effects of Dextro- and Levo-Verapamil on Sinus Node and AV Node Function in Humans
1988
Stereoselective first‐pass metabolism of highly cleared drugs: studies of the bioavailability of L‐ and D‐verapamil examined with a stable isotope technique.
1984
The interrelation of urinary calcium and sodium intake in healthy elderly Japanese.
1991
Identification of human CYP isoforms involved in the metabolism of propranolol enantiomers—N‐desisopropylation is mediated mainly by CYP1A2.
1995
Disopyramide protein binding in plasma from patients with nephrotic syndrome during the exacerbation and remission phases.
1987
Predictability of the in vivo metabolism of verapamil from in vitro data: contribution of individual metabolic pathways and stereoselective aspects.
1992
Plasma protein binding of disopyramide in pregnant and postpartum women, and in neonates and their mothers.
1990